140 related articles for article (PubMed ID: 11118037)
1. DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1.
Ng IO; Liang ZD; Cao L; Lee TK
Cancer Res; 2000 Dec; 60(23):6581-4. PubMed ID: 11118037
[TBL] [Abstract][Full Text] [Related]
2. Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells.
Zhou X; Thorgeirsson SS; Popescu NC
Oncogene; 2004 Feb; 23(6):1308-13. PubMed ID: 14647417
[TBL] [Abstract][Full Text] [Related]
3. DNA variants of DLC-1, a candidate tumor suppressor gene in human hepatocellular carcinoma.
Park SW; Durkin ME; Thorgeirsson SS; Popescu NC
Int J Oncol; 2003 Jul; 23(1):133-7. PubMed ID: 12792785
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.
Wong CM; Lee JM; Ching YP; Jin DY; Ng IO
Cancer Res; 2003 Nov; 63(22):7646-51. PubMed ID: 14633684
[TBL] [Abstract][Full Text] [Related]
5. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP.
Yuan BZ; Miller MJ; Keck CL; Zimonjic DB; Thorgeirsson SS; Popescu NC
Cancer Res; 1998 May; 58(10):2196-9. PubMed ID: 9605766
[TBL] [Abstract][Full Text] [Related]
6. DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.
Yuan BZ; Zhou X; Durkin ME; Zimonjic DB; Gumundsdottir K; Eyfjord JE; Thorgeirsson SS; Popescu NC
Oncogene; 2003 Jan; 22(3):445-50. PubMed ID: 12545165
[TBL] [Abstract][Full Text] [Related]
7. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
8. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.
Ko FC; Yeung YS; Wong CM; Chan LK; Poon RT; Ng IO; Yam JW
Liver Int; 2010 Jan; 30(1):139-48. PubMed ID: 19874489
[TBL] [Abstract][Full Text] [Related]
9. DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma.
Kim TY; Lee JW; Kim HP; Jong HS; Kim TY; Jung M; Bang YJ
Biochem Biophys Res Commun; 2007 Mar; 355(1):72-7. PubMed ID: 17292327
[TBL] [Abstract][Full Text] [Related]
10. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells.
Jie X; Lang C; Jian Q; Chaoqun L; Dehua Y; Yi S; Yanping J; Luokun X; Qiuping Z; Hui W; Feili G; Boquan J; Youxin J; Jinquan T
Oncogene; 2007 Aug; 26(39):5741-51. PubMed ID: 17369855
[TBL] [Abstract][Full Text] [Related]
11. DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas.
Yuan BZ; Jefferson AM; Baldwin KT; Thorgeirsson SS; Popescu NC; Reynolds SH
Oncogene; 2004 Feb; 23(7):1405-11. PubMed ID: 14661059
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between DLC-1 expressions and metastasis in hepatocellular carcinoma].
Song LJ; Ye SL; Wang KF; Weng YQ; Liang CM; Sun RX; Zhao Y; Liu YK; Tang ZY
Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):428-31. PubMed ID: 15975276
[TBL] [Abstract][Full Text] [Related]
13. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
14. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
15. Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression.
Lu X; Feng X; Man X; Yang G; Tang L; Du D; Zhang F; Yuan H; Huang Q; Zhang Z; Liu Y; Strand D; Chen Z
Clin Cancer Res; 2009 May; 15(10):3287-96. PubMed ID: 19447873
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
17. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma.
Chung Moh M; Hoon Lee L; Shen S
J Hepatol; 2005 Jun; 42(6):833-41. PubMed ID: 15885354
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth.
Chung GE; Yoon JH; Lee JH; Kim HY; Myung SJ; Yu SJ; Lee SH; Lee SM; Kim YJ; Lee HS
Oncol Rep; 2011 Jun; 25(6):1739-46. PubMed ID: 21455586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
